In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In a study presented at the AACR Annual Meeting 2016 on April 19, researchers engineered an organic bispecific adaptor...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved a new colorectal cancer screening test, the ‘System,...
Vice President Joe Biden spoke at the AACR Annual Meeting 2016 about the importance of breaking silos and promoting...
Data presented at the AACR Annual Meeting 2016, on April 19, showed that a microdevice about the size of...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...
The year was 1909. Tuberculosis was a leading cause of death in America, but advances in medical care had...
For all of the incredible breadth of cancer research that the AACR supports, we draw inspiration from the countless...
Guest Post by Kelsey Hampton, BS Member of the AACR’s Associate Member Council-led Communications Committee
Guest Post by Sarah Junco Wong, PhD Member of the AACR’s Associate Member Council-led Communications Committee